Latest filing published 12 Sept 2022 for Aziyo Biologics, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jerome Riebman: trading record in brief
Jerome Riebman, listed as senior executive, appears in our data through filings on Elutia Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 8 March 2022 to 8 September 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 12 September 2022, reports a share grant of €37k in Elutia Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jerome Riebman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,758 sharesClass A Common StockSEC:0001415889-22-009536:0
- 782 shares0Class A Common StockSEC:0001415889-22-002862:0
2 of 2 declarations
